Skip to content

Novel approaches in IVF.

Novel apporaches in IVF.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23935
Enrollment
400
Registered
2006-02-27
Start date
2002-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

IVF treatment.

Sponsors

Department of Reproductive Medicine, University Medical Center, Utrecht, The Netherlands.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with an indication for IVF or IVF/ Intracytoplasmic Sperm Injection (ICSI) based on tubal, male or unexplained infertility were recruited. Patients under < 38 years with a normal menstrual cycle (cycle length between period 25-35 days) and without severe obesity or underweight (body mass index (BMI) 18-28 kg/m2) were eligible for the study.

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
The primary outcome parameters chosen for this study were: 1. Pregnancy within one year of treatment after randomization leading to term (¡Ý 37 weeks gestation) live birth; 2. Total costs per couple and child up to 6 weeks after expected delivery, and (3) patient discomfort/distress during IVF treatment.

Contacts

Public ContactEsther Heijnen

Department of Reproductive Medicine, University Medical Center Utrecht, Heidelberglaan 100

esther.heijnen@organon.com

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)